TXNIP, which typically functions as a tumor suppressor, was also upregulated in 90Y-resistant cells, possibly reflecting an adaptive response to oxidative stress or altered glucose metabolism, given concurrent downregulation of DNA synthesis and cell-cycle progression genes (BIRC5, RRM2, MKI67, and CDC6). Here, TXNIP is linked to neoplasm.